Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Are all measures of liver Kp a function of F, as determined following oral dosing, or have we made a critical error in defining hepatic drug clearance?

European Journal of Pharmaceutical Sciences(2024)10.1016/j.ejps.2024.106753Source: DataRank Database

Are all measures of liver Kp a function of F, as determined following oral dosing, or have we made a critical error in defining hepatic drug clearance? is a research paper published in European Journal of Pharmaceutical Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.57)OA: goldTopics (58)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Jasleen K. Sodhi ORCID,Leslie Z. Benet ORCID

Live enrichment

PubMed:38522769 PMC:PMC11813737 OpenAlex:https://openalex.org/W4393289850

National Institutes of Health

Grant: P30 DK026743

National Institutes of Health

Grant: 5P30DK026743-27

UCSF Liver Core Center

University of California

University of California San Francisco School of Pharmacy

University of California, San Francisco

FWCI

1.57

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.ejps.2024.106753

publisherhttps://doi.org/10.1016/j.ejps.2024.106753

publisherhttps://api.elsevier.com/content/article/PII:S0928098724000642?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0928098724000642?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38522769

Fields of Study

Drug Transport and Resistance MechanismsPharmacogenetics and Drug MetabolismDrug-Induced Hepatotoxicity and Protection03 medical and health sciences0302 clinical medicineLiverHumansAdministration, OralModels, BiologicalPharmaceutical PreparationsMetabolic Clearance RateBiological AvailabilityHepatobiliary EliminationAnimalsPharmacokinetics

MeSH Terms

Administration, OralAnimalsBiological AvailabilityPharmaceutical PreparationsHumansLiverMetabolic Clearance RateModels, BiologicalPharmacokineticsHepatobiliary Elimination

Keywords

BioavailabilityDosingFirst pass effectChemistrySteady state (chemistry)Function (biology)PharmacologyMathematicsMedicineBiologyProtein bindingLiver To Blood RatioKp(uu), Hepatic BioavailabilityBiomedical and Clinical SciencesMetabolic Clearance RateLiver Disease610Administration, OralBiological AvailabilityPharmacology and Pharmaceutical SciencesModels, BiologicalKp uuHepatobiliary EliminationLiverPharmaceutical Preparations615HumansAnimalsPharmacokineticsPharmacology & PharmacyDigestive DiseasesHepatic bioavailabilityKp(uu)